Found 336 articles for: "eczema"
Efficacy and Safety of Calcipotriene 0.005%/Betamethasone Dipropionate 0.064% Foam With Apremilast for Moderate Plaque Psoriasis
September 2020 | Volume 19 | Issue 9 | Original Article | 874 | Copyright © September 2020
Objective: To demonstrate the efficacy and safety of adding fixed-dose combination calcipotriene 0.005% plus betamethasone dipropionate 0.064% (Cal/BD) foam to oral apremilast in trea...
Read MoreSystemic Medications of Dermatological Importance in COVID-19
September 2020 | Volume 19 | Issue 9 | Original Article | 889 | Copyright © September 2020
Early December 2019 witnessed an international outbreak of a novel coronavirus (COVID 19) designated severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2). Since then, a number of therapeutic m...
Read MoreTopical Cannabinoids for the Management of Psoriasis Vulgaris: Report of a Case and Review of the Literature
August 2020 | Volume 19 | Issue 8 | Case Reports | 795 | Copyright © August 2020
A Consensus About the Importance of Ceramide Containing Skincare for Normal and Sensitive Skin Conditions in Neonates and Infants
August 2020 | Volume 19 | Issue 8 | Original Article | 769 | Copyright © August 2020
Background: Neonates and infants are susceptible to skin barrier disruption as their skin anatomically and functionally is still developing. The process of skin acidification plays a ...
Read MoreDiagnosis and Management of Primary Hyperhidrosis: Practical Guidance and Current Therapy Update
July 2020 | Volume 19 | Issue 7 | Original Article | 704 | Copyright © July 2020
Hyperhidrosis is a chronic medical condition characterized by excessive sweating beyond that which is necessary for thermoregulatory homeostasis. It is estimated to occur in 4.8% of the U.S. populatio...
Read MoreDupilumab Improves Atopic Dermatitis and Post-Inflammatory Hyperpigmentation in Patient With Skin of Color
July 2020 | Volume 19 | Issue 7 | Case Reports | 776 | Copyright © July 2020
Atopic dermatitis, a chronic inflammatory condition, accounts for numerous dermatology visits for patients with skin of color. The inflammatory process often leads to post-inflammatory hyperpigmentati...
Read MoreThe Use of Botanical Extracts in East Asia for Treatment of Hyperpigmentation: An Evidenced-Based Review
July 2020 | Volume 19 | Issue 7 | Original Article | 758 | Copyright © July 2020
Recent years have seen a growth in the Asian cosmeceutical industry and an expanding worldwide marketplace with increasing consumer use of plant-based skin care products. The rising prevalence of Asia...
Read MoreDemographics and Baseline Disease Characteristics of Early Responders to Crisaborole for Atopic Dermatitis
June 2020 | Volume 19 | Issue 6 | Original Article | 619 | Copyright © June 2020
Introduction: Crisaborole ointment, 2%, is a nonsteroidal phosphodiesterase 4 inhibitor for the treatment of mild-to-moderate atopic dermatitis (AD). This post hoc, pooled analysis id...
Read MoreDevelopment of a Photonumeric Lip Health Scale
June 2020 | Volume 19 | Issue 6 | Original Article | 632 | Copyright © June 2020
Background: The lips are important facial anatomic features with particular vulnerability to environmental damage, yet they have received little attention in the dermatologic literatu...
Read MoreTreatment of Moderate to Severe Acne and Scars With a 650-Microsecond 1064-nm Laser and Isotretinoin
June 2020 | Volume 19 | Issue 6 | Original Article | 646 | Copyright © June 2020
Background: Laser procedures for acne and acne scars have traditionally been postponed for at least 6 to 8 months after the end of systemic isotretinoin therapy. Lower dosages with mo...
Read MoreNew Polymeric Once-Daily Tazarotene 0.045% Lotion Formulation for Moderate-to-Severe Acne: Pooled Phase 3 Pediatric Analysis
June 2020 | Volume 19 | Issue 6 | Original Article | 602 | Copyright © June 2020
Background: Acne vulgaris affects approximately 85% of adolescents. Topical tazarotene is efficacious and safe for acne treatment but irritation limits its use. The objective was to e...
Read MoreEffects of Colloidal Oatmeal Topical Atopic Dermatitis Cream on Skin Microbiome and Skin Barrier Properties
May 2020 | Volume 19 | Issue 5 | Original Article | 524 | Copyright © May 2020
Atopic dermatitis is characterized by dry, itchy, inflamed skin with a dysbiotic microbiome. In this clinical study (NCT03673059), we compared the effects of an eczema cream containing 1% colloidal oa...
Read MoreThe Effect of a Ceramide-Containing Product on Stratum Corneum Lipid Levels in Dry Legs
April 2020 | Volume 19 | Issue 4 | Original Article | 372 | Copyright © April 2020
Roughly equimolar concentrations of ceramides, cholesterol, and free fatty acids arranged in lamellar sheets form the intercellular lipid barrier in the stratum corneum (SC). Intercellular lipid defic...
Read MoreExacerbation of Pediatric Periorificial Dermatitis: A Novel Adverse Reaction
April 2020 | Volume 19 | Issue 4 | Editorials | 428 | Copyright © April 2020
Long-Term Benefits of Daily Photo-Protection With a Broad-Spectrum Sunscreen in United States Hispanic Female Population
March 2020 | Volume 19 | Issue 3 | Original Article | 236 | Copyright © March 2020
The skin of color population has been growing significantly in the United states and globally. This requires specific dermatological attention and patient care strategies due to unique physiological c...
Read MoreMultidisciplinary Real-World Experience With Bilastine, a Second Generation Antihistamine
February 2020 | Volume 19 | Issue 2 | Original Article | 145 | Copyright © February 2020
Introduction: Allergic conditions frequently require treatment with antihistamines. First-generation antihistamines can potentially in-terfere with restful sleep, cause “mo...
Read MoreTreatment of Impetigo in the Pediatric Population: Consensus and Future Directions
March 2020 | Volume 19 | Issue 3 | Original Article | 281 | Copyright © March 2020
Background: Impetigo is a common contagious superficial bacterial skin infection. Treatment of localized lesions can be achieved through topical antibiotics. Oral antibiotics are rese...
Read MoreAtopic Dermatitis: A Review of Current Diagnostic Criteria and a Proposed Update to Management
March 2020 | Volume 19 | Issue 3 | Original Article | 244 | Copyright © March 2020
The diagnosis of atopic dermatitis (AD) remains primarily a clinical diagnosis, in which several clinical signs and symptoms including pruritus, the presence and location of skin lesions, and a person...
Read MoreIs Dupilumab an Immunosuppressant?
February 2020 | Volume 19 | Issue 2 | Editorials | 209 | Copyright © February 2020
Atopic dermatitis (AD) is a chronic, immune-related, inflammatory skin disease that significantly reduces quality of life. In severe AD, systemic immunosuppressants are often utilized, though they do ...
Read MoreTopical Agents for the Treatment of Atopic Dermatitis
January 2020 | Volume 19 | Issue 1 | Editorials | 50 | Copyright © January 2020
Approval of the new topical phosphodiesterase 4 inhibitor crisaborole ointment, 2%, to treat mild-to-moderate atopic dermatitis (AD) warrants careful consideration of available efficacy and safety dat...
Read More